Unknown

Dataset Information

0

Novel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells.


ABSTRACT: RNA interference technology has recently been highlighted as a powerful research method as well as a potential therapeutic treatment for several diseases. However, the delivery of small interfering RNA (siRNA) into T cell lines and primary blood cells is exceedingly challenging, as they are resistant to transfection by conventional reagents. As a result, there is an unmet need for nonviral, efficient, and easily prepared carriers for siRNA delivery into hard-to-transfect cell types. Here, we report a novel system based on protein transduction domain mimics (PTDMs), generated by ring opening metathesis polymerization, for intracellular delivery of siRNA molecules. PTDM-based siRNA delivery induced efficient NOTCH1 knockdown in Jurkat T cells and human peripheral blood mononuclear cells without any measured toxicity. Furthermore, delivering siRNA to NOTCH1 in human peripheral blood cells modulated cell proliferation and differentiation of T cells into T(H)1 cells.

SUBMITTER: Tezgel AO 

PROVIDER: S-EPMC3538314 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells.

Tezgel A Özgül AÖ   Gonzalez-Perez Gabriela G   Telfer Janice C JC   Osborne Barbara A BA   Minter Lisa M LM   Tew Gregory N GN  

Molecular therapy : the journal of the American Society of Gene Therapy 20121016 1


RNA interference technology has recently been highlighted as a powerful research method as well as a potential therapeutic treatment for several diseases. However, the delivery of small interfering RNA (siRNA) into T cell lines and primary blood cells is exceedingly challenging, as they are resistant to transfection by conventional reagents. As a result, there is an unmet need for nonviral, efficient, and easily prepared carriers for siRNA delivery into hard-to-transfect cell types. Here, we rep  ...[more]

Similar Datasets

| S-EPMC3474283 | biostudies-other
| S-EPMC2694965 | biostudies-literature
| S-EPMC6222295 | biostudies-literature
| S-EPMC3867963 | biostudies-literature
| S-EPMC5800990 | biostudies-literature
| S-EPMC5167783 | biostudies-other
| S-EPMC2652357 | biostudies-literature
| S-EPMC4000586 | biostudies-literature
| S-EPMC3080021 | biostudies-literature
| S-EPMC6154102 | biostudies-literature